193 related articles for article (PubMed ID: 28835085)
1. [Management of T3 supraglottic carcinoma: a retrospective study].
Liu WS; Li ZJ; Zhang GF; Xu ZG; Tang PZ; Tu GY
Zhonghua Zhong Liu Za Zhi; 2017 Aug; 39(8):613-617. PubMed ID: 28835085
[No Abstract] [Full Text] [Related]
2. Oncological outcomes of surgical treatment for T3 supraglottic laryngeal squamous cell carcinoma patients.
Zhou J; Zhou L; Tao L; Zhang M; Wu H; Chen X; Li X; Li C; Gong H
Acta Otolaryngol; 2018 Nov; 138(11):1028-1034. PubMed ID: 30735065
[TBL] [Abstract][Full Text] [Related]
3. [Clinical analysis of 57 patients with poorly differentiated carcinomas of the supraglottic larynx].
Liu WS; Tang PZ; Qi YF; Xu ZG; Li ZJ
Zhonghua Er Bi Yan Hou Ke Za Zhi; 2004 Sep; 39(9):562-5. PubMed ID: 15606009
[TBL] [Abstract][Full Text] [Related]
4. Neck dissection with or without postoperative radiotherapy in supraglottic carcinomas.
Suárez C; Llorente JL; Nuñez F; Diaz C; Gomez J
Otolaryngol Head Neck Surg; 1993 Jul; 109(1):3-9. PubMed ID: 8336965
[TBL] [Abstract][Full Text] [Related]
5. Supraglottic laryngectomy with or without postoperative radiotherapy in supraglottic carcinomas.
Suárez C; Rodrigo JP; Herranz J; Llorente JL; Martínez JA
Ann Otol Rhinol Laryngol; 1995 May; 104(5):358-63. PubMed ID: 7747905
[TBL] [Abstract][Full Text] [Related]
6. Management of cancer of the supraglottis.
Scola B; Fernández-Vega M; Martínez T; Fernández-Vega S; Ramirez C
Otolaryngol Head Neck Surg; 2001 Feb; 124(2):195-8. PubMed ID: 11226956
[TBL] [Abstract][Full Text] [Related]
7. What is the price of functional surgical organ preservation in local-regionally advanced supraglottic cancer? Long-term outcome for partial laryngectomy followed by radiotherapy in 32 patients.
Alterio D; Ansarin M; Jereczek-Fossa BA; Zorzi S; Santoro L; Zerini D; Massaro M; Rondi E; Ferrario S; Piperno G; Cossu Rocca M; Griseri M; Preda L; Chiesa F; Orecchia R
Tumori; 2013; 99(6):667-75. PubMed ID: 24503789
[TBL] [Abstract][Full Text] [Related]
8. Laryngeal long-term morbidity after supraglottic laryngectomy and postoperative radiation therapy.
Spriano G; Antognoni P; Sanguineti G; Sormani M; Richetti A; Ameli F; Piantanida R; Luraghi R; Magli A; Corvo R; Tordiglione M; Vitale V
Am J Otolaryngol; 2000; 21(1):14-21. PubMed ID: 10668672
[TBL] [Abstract][Full Text] [Related]
9. [Surgical management and preservation of laryngeal function for senile patients with advanced laryngeal carcinoma].
Zhang DG; Zhang HB; Luan XY; Pan XL; Xie G
Zhonghua Zhong Liu Za Zhi; 2007 May; 29(5):379-81. PubMed ID: 17892137
[TBL] [Abstract][Full Text] [Related]
10. Conservation surgery for T2 and T3 carcinomas of the supraglottic larynx.
Robbins KT; Davidson W; Peters LJ; Goepfert H
Arch Otolaryngol Head Neck Surg; 1988 Apr; 114(4):421-6. PubMed ID: 3348897
[TBL] [Abstract][Full Text] [Related]
11. Clinical staging for primary malignancies of the supraglottic larynx.
Zamora RL; Harvey JE; Sessions DG; Spitznagel EL
Laryngoscope; 1993 Jan; 103(1 Pt 1):69-77. PubMed ID: 8421423
[TBL] [Abstract][Full Text] [Related]
12. Carcinoma of the supraglottic larynx: treatment results with radiotherapy alone or with planned neck dissection.
Hinerman RW; Mendenhall WM; Amdur RJ; Stringer SP; Villaret DB; Robbins KT
Head Neck; 2002 May; 24(5):456-67. PubMed ID: 12001076
[TBL] [Abstract][Full Text] [Related]
13. Radiotherapy for squamous cell carcinoma of the supraglottic larynx: an alternative to surgery.
Mendenhall WM; Parsons JT; Mancuso AA; Stringer SP; Cassisi NJ
Head Neck; 1996; 18(1):24-35. PubMed ID: 8774919
[TBL] [Abstract][Full Text] [Related]
14. [Treatment and prognosis of 264 patients with hypopharyngeal carcinoma].
Xu W; Lyu ZH; Sa N; Ma JK; Tian JJ; Feng SH; Cui P; Cao HY
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2018 May; 53(5):346-351. PubMed ID: 29764015
[No Abstract] [Full Text] [Related]
15. Horizontal partial laryngectomy for supraglottic squamous cell carcinoma.
Bron LP; Soldati D; Monod ML; Mégevand C; Brossard E; Monnier P; Pasche P
Eur Arch Otorhinolaryngol; 2005 Apr; 262(4):302-6. PubMed ID: 15316823
[TBL] [Abstract][Full Text] [Related]
16. Morbidity of combined therapy for the treatment of supraglottic carcinoma: supraglottic laryngectomy and radiotherapy.
Steiniger JR; Parnes SM; Gardner GM
Ann Otol Rhinol Laryngol; 1997 Feb; 106(2):151-8. PubMed ID: 9041821
[TBL] [Abstract][Full Text] [Related]
17. Clinical outcomes and toxicity after exclusive versus postoperative radiotherapy in supraglottic cancer: new solutions for old problems? The case of stage III and IV disease.
Costa L; Pedretti S; Foscarini F; Maddalo M; Pegurri L; Pasinetti N; Cavagnini R; Ciccarelli S; Tonoli S; Magrini SM; Buglione M
Radiol Med; 2016 Jan; 121(1):70-9. PubMed ID: 26231252
[TBL] [Abstract][Full Text] [Related]
18. Significance of laryngeal edema after partial laryngectomy and radiotherapy in supraglottic cancer.
Oksüz DC; Uzel O; Yildirim A; Yetmen O; Sahinler I; Turkan S
J Otolaryngol Head Neck Surg; 2008 Oct; 37(5):681-8. PubMed ID: 19128676
[TBL] [Abstract][Full Text] [Related]
19. CO2 laser surgery of supraglottic carcinoma: our experience over 6 years.
Pérez Delgado L; El-Uali Abeida M; de Miguel García F; Astier Peña P; Herrera Tolosana S; Lisbona Alquézar MP; Tejero-Garcés Galve G; Sevil Navarro J; Martinez-Berganza R; Ortiz García A
Acta Otorrinolaringol Esp; 2010; 61(1):12-8. PubMed ID: 19926066
[TBL] [Abstract][Full Text] [Related]
20. Radical radiotherapy for T3 laryngeal cancers.
Uno T; Itami J; Kotaka K; Toriyama M
Strahlenther Onkol; 1996 Aug; 172(8):422-6. PubMed ID: 8765344
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
